GPT and Recurrent upper respiratory tract infections: In the PH FDC SC arm, out of the five subjects who discontinued, four did so before dosing on day 1 due to two adverse events (COVID-19 infection and upper respiratory tract infection), high ALT value, and ECG abnormalities.